A Compassionate Use Study of Leronlimab in Breast Cancer
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS
Conditions: Metastatic Triple-Negative Breast Carcinoma
Interventions: DRUG: Leronlimab
Sponsor: CytoDyn, Inc.